Litigation

Recent Posts

11th Circuit Affirms Exclusion Of Plaintiff Expert In First Seroquel Bellwether
Posted on 7 Apr 2010 by Tom Moylan

ATLANTA — (Mealey’s) The sole causation expert for the first bellwether plaintiff in the Seroquel multidistrict litigation failed to rule out other causes of weight gain and diabetes, a panel of the 11th Circuit U.S. Court of Appeals said... Read More

Tags: Linda Guinn v. AstraZeneca Pharmaceuticals LP , Daubert v. Merrill Dow Pharmaceuticals , emerging drugs & devices , expert admissibility , 11th Circuit U.S. Court of Appeals , Litigation , Liknda Guinn , AstraZeneca Pharmaceuticals , Daubert , torts , Seroquel

Entire Nexium MDL Closed After Expert Excluded; Defense Awarded Costs
Posted on 10 Oct 2014 by Tom Moylan

LOS ANGELES — (Mealey’s) The California federal judge overseeing the Nexium bone injury multidistrict litigation on Oct. 8 entered judgment in favor of manufacturer defendant AstraZeneca Pharmaceuticals LP and related entities and against... Read More

Tags: In Re: Nexium [Esomeprazole] Products Liability Litigation , Judicial Panel on Multidistrict Litigation , California , product liability , Daubert v. Merrell Dow Pharmaceuticals , Litigation , Nexium , multidistrict litigation , AstraZeneca Pharmaceuticals , Daubert , MDL , torts

AstraZeneca Finalizes $520M Settlement Over Seroquel Off-Label Marketing Claims
Posted on 27 Apr 2010 by Tom Moylan

PHILADELPHIA - (Mealey's) The U.S. Department of Justice and the U.S. Department of Health and Human Services' Health Care Fraud Enforcement Action Team on April 27 announced the finalization of AstraZeneca LP and AstraZeneca Pharmaceuticals LP's... Read More

Tags: U.S. Department of Health and Human Services’ Health Care Fraud Enforcement Action Team , U.S. Department of Justice , Fraud , Litigation , lawsuit , AstraZeneca Pharmaceuticals